Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly operating margin; no daily interpolation.
Limited quarterly history available
Operating Margin needs at least three reported quarters before a meaningful chart is shown.
OPERATING MARGIN
0.00%
OPERATING MARGIN AVG TTM
N/A
OPERATING MARGIN AVG 3Y
N/A
OPERATING MARGIN AVG 5Y
N/A
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 504 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Hemab Therapeutics Holdings, Inc. Common Stock
Market Cap
$1.44B
Operating Margin
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.40B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.45B
Operating Margin
7.03%
TTM Avg
2.87%
3Y Avg
2.90%
5Y Avg
2.58%
Market Cap
$1.46B
Operating Margin
20.42%
TTM Avg
-52.76%
3Y Avg
-545.80%
5Y Avg
-384.16%
Market Cap
$1.39B
Operating Margin
-10386.54%
TTM Avg
-88055.27%
3Y Avg
-48544.96%
5Y Avg
-32630.42%
Market Cap
$1.34B
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hemab Therapeutics Holdings, Inc. Common Stock (COAG) | $1.44B | 0.00% | N/A | N/A | N/A |
| Kailera Therapeutics, Inc. (KLRA)vs › | $1.40B | 0.00% | 0.00% | 0.00% | 0.00% |
| Healthcare Services Group, Inc. (HCSG)vs › | $1.45B | 7.03% | 2.87% | 2.90% | 2.58% |
| AnaptysBio, Inc. (ANAB)vs › | $1.46B | 20.42% | -52.76% | -545.80% | -384.16% |
| Inhibrx Biosciences Inc. (INBX)vs › | $1.39B | -10386.54% | -88055.27% | -48544.96% | -32630.42% |
| Kardigan, Inc. (KARD)vs › | $1.36B | 0.00% | 0.00% | 0.00% | 0.00% |
| Braveheart Bio, Inc. (BRVE)vs › | $1.53B | N/A | N/A | N/A | N/A |
| Alpha Tau Medical Ltd (DRTS)vs › | $1.34B | 0.00% | 0.00% | 0.00% | 0.00% |
| GH Research PLC (GHRS)vs › | $1.52B | 0.00% | 0.00% | 0.00% | 0.00% |
| Innoviva, Inc. (INVA)vs › | $1.52B | 36.66% | 42.52% | 46.05% | 62.54% |
Gross Margin
0.0%
Operating Margin
0.0%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
